CSPC PHARMACEUT.GR. ADR4 (CVGU) — Cash Flow Reinvestment Rate
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Cash Flow Reinvestment Rate of 0.74x as of December 2025, reinvesting €4.33 Billion (capex €2.28 Billion plus investments €-2.05 Billion) from operating cash flow of €5.83 Billion. Check earnings quality score of CSPC PHARMACEUT.GR. ADR4 to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CSPC PHARMACEUT.GR. ADR4 Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. Explore CVGU cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Year-by-year capital reinvestment analysis for CSPC PHARMACEUT.GR. ADR4. For live market cap and broader valuation context, see CVGU market cap.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €4.33 Billion | €5.83 Billion | €2.28 Billion | ▼ -18.3% |
| 2024 | 0.91x | €4.12 Billion | €4.53 Billion | €2.68 Billion | ▼ -9.1% |
| 2023 | 1.00x | €4.18 Billion | €4.18 Billion | €1.89 Billion | ▲ +15.8% |
| 2022 | 0.86x | €6.59 Billion | €7.63 Billion | €2.72 Billion | ▲ +114.8% |
| 2021 | 0.40x | €1.86 Billion | €4.64 Billion | €1.76 Billion | — |